Sheridan M. Hoy
Mairangi Bay, AUK 0754, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 121 publications
AFREZZA® (Insulin Human) Inhalation Powder: Pediatric First Approval.
Journal: Paediatric drugs
Published: July 23, 2026
Correction to: Revakinagene Taroretcel: First Approval.
Journal: Molecular diagnosis & therapy
Published: August 12, 2025
Isatuximab: A Review in Transplant-Ineligible Newly Diagnosed Multiple Myeloma.
Journal: Targeted oncology
Published: June 08, 2025
Revakinagene Taroretcel: First Approval.
Journal: Molecular diagnosis & therapy
Published: April 30, 2025
Last Updated: 09/26/2026